Ayr Wellness (OTCMKTS:AYRWF – Get Free Report) and Nyxoah (NASDAQ:NYXH – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
Profitability
This table compares Ayr Wellness and Nyxoah’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ayr Wellness | N/A | N/A | N/A |
| Nyxoah | -543.21% | -163.73% | -80.24% |
Valuation & Earnings
This table compares Ayr Wellness and Nyxoah”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ayr Wellness | $463.63 million | 0.00 | -$359.31 million | ($1.62) | N/A |
| Nyxoah | $11.33 million | 4.92 | -$101.92 million | ($2.48) | -0.58 |
Nyxoah has lower revenue, but higher earnings than Ayr Wellness. Nyxoah is trading at a lower price-to-earnings ratio than Ayr Wellness, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings and price targets for Ayr Wellness and Nyxoah, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ayr Wellness | 0 | 0 | 0 | 0 | 0.00 |
| Nyxoah | 1 | 1 | 2 | 0 | 2.25 |
Nyxoah has a consensus target price of $5.96, indicating a potential upside of 314.35%. Given Nyxoah’s stronger consensus rating and higher possible upside, analysts clearly believe Nyxoah is more favorable than Ayr Wellness.
Insider & Institutional Ownership
0.9% of Ayr Wellness shares are owned by institutional investors. 8.1% of Ayr Wellness shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Volatility & Risk
Ayr Wellness has a beta of 1.8, meaning that its stock price is 80% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.
Summary
Ayr Wellness beats Nyxoah on 8 of the 12 factors compared between the two stocks.
About Ayr Wellness
Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
